Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension

Citation
S. Taddei et al., Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension, HYPERTENSIO, 37(3), 2001, pp. 943-948
Citations number
38
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
HYPERTENSION
ISSN journal
0194911X → ACNP
Volume
37
Issue
3
Year of publication
2001
Pages
943 - 948
Database
ISI
SICI code
0194-911X(200103)37:3<943:RONOAA>2.0.ZU;2-J
Abstract
Essential hypertension is associated with impaired endothelium-dependent va sodilation caused by oxygen free radical-induced nitric oxide (NO) breakdow n. Because calcium antagonists can improve endothelial function in patients with essential hypertension, in this study we tested the hypothesis that t his beneficial effect could be related to restoration of NO availability by antioxidant properties. In 15 healthy subjects and 15 hypertensive patient s, we studied forearm blood flow (strain-gauge plethysmography) modificatio ns induced by intrabrachial acetylcholine (ACh; 0.15, 0.45, 1.5, 4.5, and 1 5 mug/100 mt per minute), an endothelium-dependent vasodilator in basal con ditions, during infusion of N-G-monomethyl-L-arginine (L-NMMA, 100 mug/100 mt forearm tissue per minute), an NO-synthase inhibitor, vitamin C (8 mg/10 0 mt forearm tissue per minute), and finally, simultaneous infusion of L-NM MA and vitamin C. The response to sodium nitroprusside (SNP; 1, 2, and 4 mu g/100 mt forearm tissue per minute) was also evaluated. In control subjects , vasodilation to ACh was inhibited by L-NMMA and not changed by vitamin C. In hypertensive patients, vasodilation to ACh was blunted as compared with control subjects and resistant to L-NMMA. Vitamin C, which decreased plasm a isoprostanes and increased plasma antioxidant capacity, increased the res ponse to ACh and restored the inhibiting effect of L-NMMA. In hypertensive patients, the study was repeated after 3-month treatment with nifedipine ga strointestinal therapeutic system (30 to 60 mg/daily). Nifedipine treatment decreased circulating plasma lipoperoxides and isoprostanes and increased plasma antioxidant capacity. Moreover, nifedipine increased the vasodilatio n to ACh but not to SNP and restored the inhibiting effect of L-NMMA on ACh -induced vasodilation, whereas vitamin C no longer exerted its facilitating activity. These results indicate that nifedipine increases endothelium-dep endent vasodilation by restoring NO availability, an effect probably determ ined by antioxidant activity.